2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

2018 ESC/EACTS Guidelines on myocardial revascularization

M Sousa-Uva, FJ Neumann, A Ahlsson… - European Journal of …, 2019 - academic.oup.com
These Guidelines represent the third time that the ESC and EACTS have brought together
cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body …

2020 ESC Guidelines for the management of adult congenital heart disease: the Task Force for the management of adult congenital heart disease of the European …

H Baumgartner, J De Backer… - European heart …, 2021 - academic.oup.com
Force. The finalized document is approved by the CPG for publication in the European Heart
Journal. The Guidelines were developed after careful consideration of the scientific and …

2018 ESC/EACTS Guidelines on myocardial revascularization

FJ Neumann, M Sousa-Uva, A Ahlsson… - European heart …, 2019 - academic.oup.com
always refer to the full text version, which is freely available on the ESC and EACTS
websites. The National Societies of the ESC are encouraged to endorse, translate, and …

Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study

CJ Taylor, JM Ordóñez-Mena, AK Roalfe, S Lay-Flurrie… - bmj, 2019 - bmj.com
Objectives To report reliable estimates of short term and long term survival rates for people
with a diagnosis of heart failure and to assess trends over time by year of diagnosis, hospital …

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the …

JP Collet, H Thiele, E Barbato… - European heart …, 2021 - academic.oup.com
comprehensive review of the published evidence for management of a given condition
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …

Baroreflex activation therapy in patients with heart failure with reduced ejection fraction

MR Zile, JA Lindenfeld, FA Weaver, F Zannad… - Journal of the American …, 2020 - jacc.org
Background This study demonstrated the safety and effectiveness of baroreflex activation
therapy (BAT) in patients with heart failure with reduced ejection fraction (HFrEF). Objectives …

Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction

Z Li, EG Solomonidis, M Meloni, RS Taylor… - European heart …, 2019 - academic.oup.com
Aims A better understanding of the pathways that regulate regeneration of the coronary
vasculature is of fundamental importance for the advancement of strategies to treat patients …

Iron derived from autophagy-mediated ferritin degradation induces cardiomyocyte death and heart failure in mice

J Ito, S Omiya, MC Rusu, H Ueda, T Murakawa… - Elife, 2021 - elifesciences.org
Heart failure is a major public health problem, and abnormal iron metabolism is common in
patients with heart failure. Although iron is necessary for metabolic homeostasis, it induces a …

Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial

LM Ruilope, R Agarwal, SD Anker, GL Bakris… - American journal of …, 2019 - karger.com
Background: Among people with diabetes, those with kidney disease have exceptionally
high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying …